We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Peridot Acquisition Corp II | NYSE:PDOT | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.18 | 0 | 00:00:00 |
Cayman Islands |
001-40180 |
98-1586920 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
Title of Each Class: |
Trading Symbol: |
Name of Each Exchange on Which Registered: | ||
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant |
PDOT.U |
New York Stock Exchange | ||
Class A ordinary shares included as part of the units |
PDOT |
New York Stock Exchange | ||
Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |
PDOT WS |
New York Stock Exchange |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
• | “amended and restated memorandum and article of association” are to the amended and restated memorandum and articles of association of the Company adopted on March 8, 2021; |
• | “Carnelian” are to Carnelian Energy Capital Management, L.P., an affiliate of our sponsor; |
• | “Class A ordinary shares” are to our Class A ordinary shares, $0.0001 par value; |
• | “Class B ordinary shares” are to our Class B ordinary shares, $0.0001 par value; |
• | “Companies Act” are to the Companies Act (As Revised) of the Cayman Islands as the same may be amended from time to time; |
• | “founder shares” are to our Class B ordinary shares initially issued to our sponsor in a private placement prior to our initial public offering and the Class A ordinary shares that will be issued upon the automatic conversion of the Class B ordinary shares at the time of our initial business combination (for the avoidance of doubt, such Class A ordinary shares will not be “public shares”); |
• | “management” or our “management team” are to our executive officers and directors; |
• | “ordinary shares” are to our Class A ordinary shares and our Class B ordinary shares; |
• | “private placement warrants” are to the warrants issued to our sponsor in a private placement simultaneously with the closing of our initial public offering and upon conversion of working capital loans, if any; |
• | “public shares” are to our Class A ordinary shares sold as part of the units in our initial public offering (whether they were purchased in the initial public offering or thereafter in the open market); |
• | “public shareholders” are to the holders of our public shares, including our sponsor and management team to the extent our sponsor and/or members of our management team purchase public shares, provided that our sponsor’s and each member of our management team’s status as a “public shareholder” will only exist with respect to such public shares; |
• | “sponsor” are to Peridot Acquisition Sponsor II, LLC, a Delaware limited liability company; and |
• | “we,” “us,” “our,” “company” or “our company” are to Peridot Acquisition Corp. II, a Cayman Islands exempted company. |
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial business combination; |
• | our expectations around the performance of a prospective target business or businesses; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | our ability to consummate an initial business combination due to the uncertainty resulting from the recent COVID-19 pandemic; |
• | the ability of our officers and directors to generate a number of potential business combination opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
• | the trust account not being subject to claims of third parties; |
• | our financial performance: or |
• | the other risks and uncertainties discussed in “Risk Factors” and elsewhere in this Report. |
Item 1. |
Business |
• | We issue ordinary shares that will be equal to or in excess of 20% of the number of our ordinary shares then-outstanding (other than in a public offering); |
• | Any of our directors, officers or substantial security holder (as defined by the NYSE rules) has a 5% or greater interest, directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in issued and outstanding ordinary shares or voting power of 1% or more (or 5% or more if the related party involved is classified as such solely because such person is a substantial security holder); or The issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
Item 1A. |
Risk Factors |
• | may significantly dilute the equity interest of investors in our initial public offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one |
• | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
• | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and |
• | may not result in adjustment to the exercise price of our warrants. |
• | solely dependent upon the performance of a single business, property or asset; or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. |
• | registration as an investment company with the SEC; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are currently not subject to. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our Class A ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | we have a board that includes a majority of “independent directors,” as defined under the rules of the NYSE; |
• | we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
• | we have a nominating and corporate governance committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. |
• | costs and difficulties inherent in managing cross-border business operations; |
• | rules and regulations regarding currency redemption; |
• | complex withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | exchange listing and/or delisting requirements; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | local or regional economic policies and market conditions; |
• | unexpected changes in regulatory requirements; |
• | longer payment cycles; |
• | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | underdeveloped or unpredictable legal or regulatory systems; |
• | corruption; |
• | protection of intellectual property; |
• | social unrest, crime, strikes, riots and civil disturbances; |
• | regime changes and political upheaval; |
• | terrorist attacks, natural disasters and wars; and |
• | deterioration of political relations with the United States. |
Item 1B. |
Unresolved Staff Comments |
Item 2. |
Properties |
Item 3. |
Legal Proceedings |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities |
Item 6. |
Selected Financial Data. |
Item 7. |
Management’s discussion and analysis of financial condition and results of operations |
Item 7A. |
Quantitative and Qualitative Disclosures about Market Risk |
Item 8. |
Financial Statements and Supplementary Data |
Item 9. |
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
Item 9A. |
Controls and Procedures. |
Item 9B. |
Other Information |
Item 9C. |
Disclosures Regarding Foreign Jurisdictions That Prevent Inspection |
Item 10. |
Directors, Executive Officers and Corporate Governance Directors and Executive Officers |
Name |
Age |
Position | ||
Tomas Ackerman |
42 | Chairman of the Board | ||
Preston Powell |
35 | Chief Executive Officer and Director | ||
Stephen Wedemeyer |
42 | Chief Financial Officer | ||
Alan Levande |
65 | Vice Chairman | ||
Scott Prochazka |
56 | Director | ||
June Yearwood |
56 | Director |
• | meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems; |
• | monitoring the independence of the independent registered public accounting firm; |
• | verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; |
• | inquiring and discussing with management our compliance with applicable laws and regulations; |
• | pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; |
• | appointing or replacing the independent registered public accounting firm; |
• | determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; |
• | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; |
• | monitoring compliance on a quarterly basis with the terms of our initial public offering and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of our initial public offering; and |
• | reviewing and approving all payments made to our existing shareholders, executive officers or directors and their respective affiliates. Any payments made to members of our Audit Committee are reviewed and approved by our board of directors, with the interested director or directors abstaining from such review and approval. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our President’s, Chief Financial Officer’s and Chief Operating Officer’s, evaluating our President’s, Chief Financial Officer’s and Chief Operating Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our President, Chief Financial Officer and Chief Operating Officer based on such evaluation; |
• | reviewing and approving the compensation of all of our other Section 16 executive officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
Individual |
Entity |
Entity’s business |
Affiliation | |||
Alan Levande |
Covey Park Holdings LLC | Oil and Natural Gas Exploration & Production | Officer and Director | |||
Li-Cycle Corp. |
Lithium-ion Battery Recycling |
Director | ||||
Stephen Wedemeyer |
Carnelian Energy Capital (1) |
Private Equity | Chief Financial Officer | |||
Tomas Ackerman |
Carnelian Energy Capital (1) |
Private Equity | Partner | |||
Preston Powell |
Carnelian Energy Capital (1) |
Private Equity | Managing Director | |||
June Yearwood |
The Church Pension Fund | Pension Fund | Managing Director | |||
State of New York Teachers’ Retirement System | Pension Fund | Member of Investment Advisory Committee |
(1) | Includes certain of its funds and other affiliates. |
• | Our executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our executive officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our executive officers are not obligated to contribute any specific number of hours per week to our affairs. |
• | Our sponsor subscribed for founder shares prior to our initial public offering and purchased private placement warrants in a transaction that closed simultaneously with the closing of our initial public offering. |
• | Our sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion of our initial business combination and (ii) a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial public offering or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares. Additionally, our sponsor has agreed to waive its rights to liquidating distributions from the trust account with respect to its founder shares if we fail to complete our initial business combination within the prescribed time frame. If we do not complete our initial business combination within the prescribed time frame, the private placement warrants will expire worthless. Except as described herein, our sponsor and our directors and executive officers have agreed not to transfer, assign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement warrants will not be transferable until 30 days following the completion of our initial business combination. Because each of our executive officers and directors will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. |
• | Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors is included by a target business as a condition to any agreement with respect to our initial business combination. In addition, certain members of our management team may in the future form or participate in other blank check companies similar to ours during the period in which we are seeking an initial business combination. Any such companies may present additional conflicts of interest in pursuing an acquisition target, particularly in the event there is overlap among investment mandates. |
Item 11. |
Executive Compensation Executive Officer and Director Compensation |
Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters |
• | each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; |
• | each of our executive officers and directors that beneficially owns ordinary shares; and |
• | all our executive officers and directors as a group. |
Approximate Percentage of Issued and Outstanding Ordinary Shares |
||||||||||||||||
Number of Shares Beneficially Owned (2) |
Name and Address of Beneficial Owner (1) |
Before Offering |
After Offering |
|||||||||||||
Peridot Acquisition Sponsor II, LLC (our sponsor) |
10,121,369 | (3)(4) |
99.0 | % | 19.8 | % | ||||||||||
Tomas Ackerman |
10,121,369 | (3)(4) |
99.0 | % | 19.8 | % | ||||||||||
Preston Powell |
— | — | — | |||||||||||||
Stephen Wedemeyer |
— | — | — | |||||||||||||
Alan Levande |
30,000 | * | * | |||||||||||||
June Yearwood |
30,000 | * | * | |||||||||||||
Scott Prochazka |
30,000 | * | * | |||||||||||||
All officers and directors as a group (six individuals) |
10,211,369 | (4) |
100 | % | 20.0 | % |
* | Less than one percent. |
(1) | Unless otherwise noted, the business address of each of our shareholders is 2229 San Felipe Street, Suite 1450, Houston, TX 77019. |
(2) | Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof as described in the section entitled “Description of Securities.” |
(3) | The shares reported above are held in the name of our sponsor. CEC Aventurine Holdings, LLC (“Aventurine Holdings”) shares voting and/or dispositive control over the securities held by our sponsor. Aventurine Holdings is controlled by Carnelian Energy Capital III, L.P. (“Carnelian Fund III”), its sole member. Carnelian Fund III is controlled by its general partner, Carnelian Energy Capital GP III, L.P. (“Carnelian L.P.”) and Carnelian L.P. is controlled by its general partner Carnelian Energy Capital Holdings, LLC (“Carnelian Holdings”). Messrs. Tomas Ackerman and Daniel Goodman are the controlling members of Carnelian Holdings. Accordingly, all of the shares held by our sponsor may be deemed to be beneficially held by Aventurine Holdings, Carnelian Fund III, Carnelian L.P., Carnelian Holdings and Messrs. Ackerman and Goodman. Each such entity or person disclaims beneficial ownership of these securities. |
Item 13. |
Certain Relationships and Related Transactions, and Director Independence |
Item 14 . |
Principal Accountant Fees and Services. |
Item 15 . |
Exhibits, Financial Statement Schedules |
(a) | The following documents are filed as part of this Form 10-K: |
(1) | Financial Statements: |
Page |
||||
Report of Independent Registered Public Accounting Firm |
F-2 |
|||
Balance Sheets |
F-3 |
|||
Statements of Operations |
F-4 |
|||
Statements of Changes in Shareholders’ Deficit |
F-5 |
|||
Statements of Cash Flows |
F-6 |
|||
Notes to Financial Statements |
F-7 |
(2) | Financial Statement Schedules: |
(3) | Exhibits |
* | Filed herewith. |
Item 16. |
Form 10-K Summary |
PERIDOT ACQUISITION CORP. II | ||
/s/ Preston Powell | ||
Name: Preston Powell | ||
Title: Chief Executive Officer (Principal Executive Officer) |
Name |
Position |
Date | ||
/s/ Preston Powell |
Chief Executive Officer (Principal Executive Officer) |
March 31, 2022 | ||
Preston Powell | ||||
/s/ Stephen Wedemeyer |
Chief Financial Officer (Principal Financial and Accounting Officer) |
March 31, 2022 | ||
Stephen Wedemeyer | ||||
/s/ Scott Prochazka |
Director | March 31, 2022 | ||
Scott Prochazka | ||||
/s/ Alan Levande |
Vice Chairman | March 31, 2022 | ||
Alan Levande | ||||
/s/ June Yearwood |
Director | March 31, 2022 | ||
June Yearwood |
General and administrative expenses |
$ | 1,606,123 | ||
Loss from operations |
(1,606,123 |
) | ||
Other income (expense): |
||||
Change in fair value of warrant liabilities |
2,383,964 | |||
Transaction costs allocated to warrant liabilities |
(465,914 | ) | ||
Interest income – bank |
36 | |||
Interest earned on investments held in Trust Account |
102,660 | |||
Total other income, net |
2,020,746 | |||
Net income |
$ |
414,623 |
||
Weighted average shares outstanding of Class A ordinary shares |
33,670,427 | |||
Basic net income per share, Class A ordinary shares |
$ |
0.01 |
||
Weighted average shares outstanding of Class B ordinary shares |
9,980,632 | |||
Basic net income per share, Class B ordinary shares |
$ |
0.01 |
||
Weighted average shares outstanding of Class A ordinary shares |
33,670,427 | |||
Diluted net income per share, Class A ordinary shares |
$ |
0.01 |
||
Weighted average shares outstanding of Class B ordinary shares |
10,211,369 | |||
Diluted net income per share, Class B ordinary shares |
$ |
0.01 |
||
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in |
Accumulated |
Total Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance – January 8, 2021 (inception) |
— |
$— |
— |
$ — |
$ — |
$ — |
$ — |
|||||||||||||||||||||
Issuance of Class B ordinary shares to Sponsor |
— | — | 10,350,000 | 1,035 | 23,965 | — | 25,000 | |||||||||||||||||||||
Cash paid in excess of fair value of Private Placement Warrant s |
— | — | — | — | 203,382 | — | 203,382 | |||||||||||||||||||||
Accretion for Class A ordinary shares to redemption amount |
— | — | — | — | (227,361 | ) | (30,365,528 | ) | (30,592,889 | ) | ||||||||||||||||||
Forfeiture of Founder Shares |
— |
— |
(138,631 | ) | (14 | ) | 14 | — |
— |
|||||||||||||||||||
Net income |
— |
— |
— |
— |
— |
414,623 | 414,623 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – December 31, 2021 |
— |
$ |
— |
10,211,369 |
$ |
1,021 |
$ |
— |
$ |
(29,950,905 |
) |
$ |
(29,949,884 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities: |
||||
Net income |
$ | 414,623 | ||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Formation costs paid by Sponsor |
5,000 | |||
Interest earned on investments held in Trust Account |
(102,660 | ) | ||
Change in fair value of warrant liabilities |
(2,383,964 | ) | ||
Transaction costs allocated to warrant liabilities |
465,914 | |||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
(498,983 | ) | ||
Accrued expenses |
883,637 | |||
Net cash used in operating activities |
(1,216,433 |
) | ||
Cash Flows from Investing Activities: |
||||
Investment of cash in Trust Account |
(408,454,760 | ) | ||
Net cash used in investing activities |
(408,454,760 | ) | ||
Cash Flows from Financing Activities: |
||||
Proceeds from sale of Units, net of underwriting discounts paid |
400,285,665 | |||
Proceeds from sale of Private Placement Warrants |
10,169,095 | |||
Proceeds from promissory note – related party |
29,878 | |||
Repayment of promissory note – related party |
(140,368 | ) | ||
Payment of offering costs |
(457,588 | ) | ||
Net cash provided by financing activities |
409,886,682 | |||
Net Change in Cash |
215,489 |
|||
Cash – Beginning of period |
— | |||
Cash – End of period |
$ |
215,489 |
||
Non-Cash investing and financing activities: |
||||
Offering costs paid by Sponsor in exchange for the issuance of Founder Shares |
$ | 20,000 | ||
Offering costs paid through promissory note |
$ | 110,490 | ||
Deferred underwriting fee payable |
$ | 14,295,917 | ||
Forfeiture of Founder Shares |
$ | (14 | ) | |
Balance Sheet as of March 11, 2021 |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Ordinary shares subject to possible redemption |
$ |
327,759,920 |
$ |
32,240,080 |
$ |
360,000,000 |
||||||
Class A Ordinary shares |
$ |
322 |
$ |
(322 |
) |
$ |
— |
|||||
Additional paid-in capital |
$ |
5,417,325 |
$ |
(5,417,325 |
) |
$ |
— |
|||||
Accumulated deficit |
$ |
(418,679 |
) |
$ |
(26,822,433 |
) |
$ |
(27,241,112 |
) | |||
Total Shareholders’ Equity (Deficit) |
$ |
5,000,003 |
$ |
(32,240,080 |
) |
$ |
(27,240,077 |
) |
Gross proceeds |
$ | 408,454,760 | ||
Less: |
||||
Proceeds allocated to Public Warrants |
$ | (8,005,713 | ) | |
Class A ordinary shares issuance costs |
$ | (22,587,176 | ) | |
Plus: |
||||
Accretion of carrying value to redemption value |
$ | 30,592,889 | ||
|
|
|||
Class A ordinary shares subject to possible redemption |
$ | 408,454,760 |
For the Period from January 15, 2021 (inception) through December 31, 2021 |
||||||||
Class A |
Class B |
|||||||
Basic and diluted net income per ordinary share |
||||||||
Numerator: |
||||||||
Allocation of net income, as adjusted |
$ | 319,821 | $ | 94,802 | ||||
Denominator: |
||||||||
Basic weighted average shares outstanding |
33,670,427 | 9,980,632 | ||||||
|
|
|
|
|||||
Basic net income per ordinary share |
$ | 0.01 | $ | 0.01 | ||||
Diluted net income per ordinary share |
||||||||
Numerator: |
||||||||
Allocation of net income, as adjusted |
$ | 318,140 | $ | 96,482 | ||||
Denominator: |
||||||||
Diluted weighted average shares outstanding |
33,670,427 | 10,211,369 | ||||||
Diluted net income per ordinary share |
$ | 0.01 | $ | 0.01 |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Class A ordinary shares; |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
• | if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Description |
Level |
December 31, 2021 |
||||||
Assets: |
||||||||
Investments held in Trust Account – U.S. Treasury Securities Money Market Fund |
1 | $ | 408,557,420 | |||||
Liabilities: |
||||||||
December 31, 2021 – Public Warrants |
1 | 6,943,731 | ||||||
December 31, 2021 – Private Placement Warrants |
2 | 8,643,731 |
Public |
Private Placement |
Warrant Liabilities |
||||||||||
Fair value as of Inception |
$ | — | $ | — | $ | — | ||||||
Initial measurement on March 11, 2021 and March 17, 2021 |
8,005,713 | 9,965,713 | 17,971,426 | |||||||||
Change in valuation inputs or other assumptions |
(1,061,982 | ) | (1,321,982 | ) | (2,383,964 | ) | ||||||
Transfer to Level 1 |
(6,943,731 | ) | — | (6,943,731 | ) | |||||||
Transfer to Level 2 |
— | (8,643,731 | ) | (6,643,731 | ) | |||||||
|
|
|
|
|
|
|||||||
Fair value as of December 31, 2021 |
— | — | — | |||||||||
|
|
|
|
|
|
1 Year Peridot Acquisition Corp... Chart |
1 Month Peridot Acquisition Corp... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions